drugset
Drugs / Menhibrix
last change May 2011 re-read 2 minutes ago

Menhibrix

also known as Hib-MenCY-TT · GSK 792014

Vaccine

Developed for
meningococcal infection · haemophilus infectious disease
Investigated by
GlaxoSmithKline

Trials 7 · a red edge is where a trial was stopped

today NCT00614614 · Ph 3 NCT00345683 · Ph 3 NCT00345579 · Ph 3 NCT00359983 · Ph 3 NCT00289783 · Ph 3 NCT00134719 · Ph 2 NCT00129129 · Ph 2
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT00134719 Apr 2005 → Jul 2006 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT00129129 Aug 2004 → Sep 2005 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded
Phase 35 trials
Phase 3 NCT00614614 Feb 2008 → Jul 2009 meningococcal infection GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00345683 Jul 2007 → Sep 2008 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00345579 Sep 2006 → Oct 2007 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00359983 Sep 2006 → Nov 2007 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00289783 Feb 2006 → Aug 2007 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Menhibrix “Subjects received 3 doses of Menhibrix vaccine (at 2, 4 and 6 months of age, study Months 0, 2 and 4), co-administered with Pediarix/Infanrix penta as a primary vaccination...” NCT00345683 ↗
6

“Subjects were primed with 3 doses of Menhibrix vaccine Lot A co-administered with Pediarix and boosted with 1 dose of Menhibrix vaccine, with co-administration of M-M-R II and Varivax.” NCT00289783 ↗

“Subjects received 3 doses of Menhibrix vaccine (at 2, 4 and 6 months of age, study Months 0, 2 and 4)” NCT00345579 ↗

“received 3 doses of Menhibrix™ co-administered with Pediarix™ and Prevnar™” NCT00129129 ↗

NCT00134719 ↗

NCT00614614 ↗

NCT00359983 ↗
Known as GSK 792014 “GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix)” NCT00614614 ↗
Known as Hib-MenCY-TT “Biological: MenHibrix (Hib-MenCY-TT)” NCT00134719 ↗
1

“MenHibrix (Hib-MenCY-TT)” NCT00359983 ↗
Modality Vaccine “Menhibrix vaccine” NCT00345579 ↗
Route Intramuscular “Menhibrix™ was administered intramuscularly (IM)” NCT00129129 ↗